Skip to main content
. 2020 Dec 30;37:385. doi: 10.11604/pamj.2020.37.385.27140

Table 5.

summary of findings on Vaccine Preventable Diseases Surveillance

Domain Number (n) Percentage (%)
Clear terms of reference available for subnational surveillance focal persons 15 75
Limitation of financial resources for VPD surveillance 8 40
Prioritization of surveillance sites being done regularly for active surveillance 15 75
Health workers knowledgeable on the standard reporting case definition of priority VPDs, surveillance monitoring indicators and outbreak definitions 10 50
Regular data review and harmonization not done between the immunisation, surveillance and lab teams 7 35
National surveillance guidelines available at health facility level 13 65
Inadequate monitoring of key surveillance quality performance indicators and disease trends 6 30
No surveillance work plan 1 5
Limited capacity of the National Public Health Laboratory 1 5